Press Releases

Worldwide “Benign Prostatic Hyperplasia Market” Size is expected to grow at a CAGR of 8.5% from 2018-2023 | Forecast Analysis by Product Type, by Main Application, by top Regions

Benign Prostatic Hyperplasia

“Latest Market Overview for Benign Prostatic Hyperplasia Market Research Report 2018-2023 with CAGR 8.5%

Global Benign Prostatic Hyperplasia Market Report 2018 provides actionable intelligence on factors that have been driving demand; key trends that are impacting the Benign Prostatic Hyperplasia marketchallenges that affect the market dynamics along with the market size, a SWOT analysis of the key vendors, and various segments.

Competitor Analysis: by product types, market share, applications, sales, and revenue.

  • Allergan PLC
  • Astellas Pharma Inc.
  • Boehringer Ingelheim
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Nymox Pharmaceutical Corporation
  • Pfizer
  • Inc
  • Sanofi
  • Sophiris Bio Corp
  • and Teva Pharmaceutical Industries Limited
  • among others.

Get Sample Copy of this Report https://www.360researchreports.com/enquiry/request-sample/13104480

Description of Benign Prostatic Hyperplasia Market: Benign Prostatic Hyperplasia Market Overview

The benign prostatic hyperplasia market is expected to register a CAGR of approximately 8.5% over the forecast period, 2018-2023. Benign prostatic hyperplasia (BPH) also known as benign prostatic hypertrophy is characterized by the unusual propagation of the prostatic cells, which causes difficulties like urinary retention and infections of the urinary tract. It is most common among the aging men population, primarily driving this market. On the basis of geographical analysis, the North American region is expected to retain its dominance in this market owing to better healthcare infrastructure, high healthcare expenditure on urological disorders, increased awareness in the society increasing the outpatients center and hospitals visits.

Rising Geriatric Population to Induce a Surge in the Benign Prostatic Hyperplasia Market

Benign prostatic hyperplasia (BPH) is being accepted as a growing health problem of elderly men. With the rising number of elderly males in the population, the degree of the problem is projected to rise multifold over the next few years. As per a publication of 2018 in the United States Census Bureau the population of people aged 65 and above in the US would increase drastically between 2016 and 2060 period. By 2030, one in five US citizens is expected to be 65 years and older, crossing 78.0 million. The diseased population is also significantly increased in the emerging markets. The advancements in early diagnosis of the disease and geriatric population along with adults drive the demand for the benign prostatic hyperplasia market.
In addition, the other factors contributing to driving this market include technological advancements in personalized medicines and rising awareness in the society through campaigns.

Non-adherence of Patients to Pharmacological Therapy will impede the Growth of Benign Prostatic Hyperplasia Market

Patient adherence to therapeutics for Benign Prostatic Hyperplasia is low. Especially, the need for usage of a combination of two drugs for the treatment of BPH characterizes is among the major hurdle for adherence of patients to pharmacotherapy. Persistence on therapeutic approach is generally associated with a lower rate of hospitalization for complications regarding BPH. This is more associated with social stigma mainly in low and middle-income countries. The majority of patients rely on the conservative management, particularly in Asian countries. According to data published in 2015, in BioMed Central, a significantly lesser percentage of males suffering from BPH try to seek for any medical assistance and even lesser go for the pharmacological treatment. Thus, it is considered among the major hindrance in the growth of the benign prostatic hyperplasia market.
Another evolving barrier in this market includes increasing preference for the minimally invasive surgeries.

North America expected to Lead the Benign Prostatic Hyperplasia Market

North America dominates the market owing to the high prevalence of BPH and other associated lower urinary tract symptoms. Several studies in past one era have reported a significant percentage of men in the US, aged between 45 and 80 years suffer from some type of lower urinary tract symptoms and mostly have some form of BPH symptoms. In addition, several hospitals across the US, and Canada have collaboration with the non-profit organization and companies such as GlaxoSmithKline in some of the projects to raise awareness and adequate resources for the treatment of urological disorders. Thus, it acts a very lucrative market for the companies contributing to a large share of this market. Europe and Asia Pacific region are expected to follow next.

Reasons to Purchase the Benign Prostatic Hyperplasia Market Report

  • Current and future Benign Prostatic Hyperplasia Market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

    Order a copy of Benign Prostatic Hyperplasia Market Report 2018 @ https://www.360researchreports.com/purchase/13104480

    The Global demand for Benign Prostatic Hyperplasia Market is forecast to report strong development driven by consumption in major evolving markets. More growth opportunities to come up between 2018 and 2025 compared to a few years ago, signifying the rapid pace of change.

    Following market aspects are enfolded in Global Benign Prostatic Hyperplasia Market Report:

    1. A wide summarization of the Global Benign Prostatic Hyperplasia Market.
    2. The present and forecasted regional market size data based on applications, types, and regions.
    3. Market trends, drivers and challenges for the Global Benign Prostatic Hyperplasia Market.
    4. Analysis of company profiles of Top major players functioning in the market.

    Benign Prostatic Hyperplasia Market report passes on a fundamental overview of the Market including its definition, applications, and advancement. Furthermore, the Industry report investigates the ecumenical Major Benign Prostatic Hyperplasia Market players in detail. Benign Prostatic Hyperplasia Market report gives key bits of Cautiousness and subsisting status of the Players and is a basic Source obviously and heading for Companies and people energized by the Industry.

    Inquire more or share questions if any for this Report @ https://www.360researchreports.com/enquiry/pre-order-enquiry/13104480

    Which are the important factors that are mentioned in the Benign Prostatic Hyperplasia Market report 2023?

    • Key Market Dynamics: The Global Benign Prostatic Hyperplasia Market research report provides complete forecasts on the latest market trends, development methods, and research methodologies. Some of the factors that are directly in affecting the market including the Strategic Production and Methods, development platforms, and the product model itself, and even a minute change within the product profile would result in huge amount of changes within the mentioned factors. All of these factors are explained in detail in the research study.
    • Major Growth Prospects:The report also focuses on some of the Key growth prediction, including new product launches, Mergers and Acquisitions, Research and Development, joint ventures, collaborations, agreements, partnerships, and growth of the key Manufacturers working effectively in the market, both in terms of regional and global scale depending on geography.
    • Key Market Highlights: The report gives us an in-depth Market analysis on some of the Benign Prostatic Hyperplasia Market key factors, including revenue, cost, capacity, capacity utilization rate, production, production rate, consumption, supply, demand, Market share, CAGR, and gross margin. Additionally, the report presents a comprehensive study of the market growth factors and their latest trends, along with related Market sections and subsections.

    Browse Detailed TOC, Tables, Figures, Charts, and Companies Mentioned in this Market Research Report @ https://360researchreports.com/Benign Prostatic Hyperplasia-13104480

     The growth of this market worldwide is subjected to various factors; including consumer world-class Benign Prostatic Hyperplasia Market of many Benign Prostatic Hyperplasia Market products, inorganic company growth models, price volatility of raw materials, product innovation along with economic prospects in both producer and consumer countries.

    Conclusively, this report will provide you a clear view of each fact of the market without a need to refer to any other research report or a data source. Our report will provide you with all the facts about the past, present, and future of the concerned Market.